Results 11 to 20 of about 11,106 (236)
Epsilon aminocaproic acid (EACA) myopathy [PDF]
Postgraduate Medical Journal, 1979 SummaryTwo female patients developed a severe, painful proximal myopathy after taking 18–30 g of epsilon-aminocaproic acid daily for 5 weeks. Marked elevations of serum aminotransferases, creatine kinase and aldolase levels were found and the first patient had electromyographic and muscle biopsy changes of an acute monophasic, necrotising myopathy at ...
R. Lane +3 more
openalex +4 more sources
High Dose, Prolonged Epsilon Aminocaproic Acid Infusion, and Recombinant Factor VII for Massive Postoperative Retroperitoneal Hemorrhage following Splenectomy. [PDF]
Case Rep Anesthesiol, 2016 The antifibrinolytic agent ε-aminocaproic acid is used to decrease procedural blood loss in a variety of high risk surgeries. The utility of recombinant factor VII administration in massive hemorrhage has also been reported in a variety of settings ...
Lee AT, Barnes CR, Jain S, Pauldine R.
europepmc +2 more sources
Effects of Epsilon-Aminocaproic Acid on the Tuberculin Reaction in Man
Journal of Investigative Dermatology, 1964 Epsilon-amino caproic acid (EACA) is an inhibitor of plasminogen activators (1, 2) which has been used clinically to prevent bleeding (3). It has also been reported to have various antiinflammatory and “anti-allergic” effects, presumably by virtue of its anti-fibrinolytic and anti-proteolytic qualities.
Edmund D. Lowney
openalex +4 more sources
Epsilon-aminocaproic acid therapy in ulcerative colitis [PDF]
Gut, 1970 On the supposition that excessive fibrinolysis at the rectal mucosal level may contribute to the pathogenesis of ulcerative colitis, 11 patients with this condition, in whom rectal bleeding was the predominant feature, were given a course of epsilon-aminocaproic acid therapy.
R H Salter, A. E. Read
openalex +4 more sources
Systemic allergic dermatitis to epsilon‐aminocaproic acid [PDF]
Contact Dermatitis, 2009 A 47-year-old Caucasian woman had a pruriginous dermatitis involving her axillary, infra-mammary and inguinal flexures, and the lateral aspects of her trunk. Confluent erythematous patches without epidermal detachment were observed, sparing the extremities and mucous membranes (Fig. 1). There were no systemic symptoms.
Daniela Cunha +3 more
openalex +5 more sources
Antifibrinolytic Activity During Administration of Epsilon-Aminocaproic Acid [PDF]
Stroke, 1971 Utilizing an in vitro method for activated and nonactivated whole blood clotlysis determinations, the antifibrinolytic effect of epsilon-aminocaproic acid therapy was evaluated. Initially, the induced antifibrinolytic activity diminished within two hours after the previous dose.
Donald W. Nibbelink
openalex +3 more sources
Commentary: Epsilon-aminocaproic acid versus tranexamic acid, the David and Goliath of antifibrinolytics. [PDF]
JTCVS Open, 2020 Faraoni D.
europepmc +2 more sources
Comparison of intraoperative tranexamic acid and epsilon-aminocaproic acid in cardiopulmonary bypass patients. [PDF]
JTCVS Open, 2020 Broadwin M +6 more
europepmc +2 more sources